Cargando…

Revisit the signatures of γδ T cells in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Gao, Yanan, You, Maojun, Yang, Pengyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092003/ https://www.ncbi.nlm.nih.gov/pubmed/35538898 http://dx.doi.org/10.1002/ctm2.859

Ejemplares similares

Revisiting the Interaction of γδ T-Cells and B-Cells
por: Rampoldi, Francesca, et al.
Publicado: (2020)

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma
por: Wang, Jingrui, et al.
Publicado: (2022)

3D modelling of γδ T‐cell immunotherapy
por: Hull, Caroline M., et al.
Publicado: (2022)

3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022)

Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2(+) γδ T cell can be a promising complement
por: He, Wenjing, et al.
Publicado: (2022)

An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma
por: Peng, Wang, et al.
Publicado: (2023)

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
por: Anderson, John, et al.
Publicado: (2023)

Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation
por: Gaballa, Ahmed, et al.
Publicado: (2021)

Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs
por: Murai, Nobuyuki, et al.
Publicado: (2023)

Antigen recognition by human γδ T cells: one step closer to knowing
por: Eberl, Matthias
Publicado: (2020)

Cancer stem cells in hepatocellular carcinomas
por: Das, Prasenjit, et al.
Publicado: (2015)

Revisiting regulatory T cells for stroke therapy
por: Lee, Juneyoung, et al.
Publicado: (2022)

Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)

Revisiting the revisit: added evidence for a social chemosignal in human emotional tears
por: Sobel, Noam
Publicado: (2017)

Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance
por: Hu, Yi, et al.
Publicado: (2022)

γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors
por: Tian, Wei, et al.
Publicado: (2018)

A diversified role for γδT cells in vector-borne diseases
por: Chen, Chen, et al.
Publicado: (2022)

Overexpression of miR-382 Sensitizes Hepatocellular Carcinoma Cells to γδ T Cells by Inhibiting the Expression of c-FLIP
por: Chen, Zhong, et al.
Publicado: (2020)

Peptide vaccines for hepatocellular carcinoma
por: Nobuoka, Daisuke, et al.
Publicado: (2013)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

A gene expression signature of TREM2(hi) macrophages and γδ T cells predicts immunotherapy response
por: Xiong, Donghai, et al.
Publicado: (2020)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

AHR Signaling Dampens Inflammatory Signature in Neonatal Skin γδ T Cells
por: Merches, Katja, et al.
Publicado: (2020)

Revisiting the Sham: Is It all Smoke and Mirrors?
por: Horn, Brandon, et al.
Publicado: (2011)

The high-risk surgical patient revisited
por: Bennett, David
Publicado: (1998)

Revisiting Respect for Persons in Genomic Research
por: Mathews, Debra J.H., et al.
Publicado: (2014)

Incidental findings in population imaging revisited
por: Bunnik, Eline M., et al.
Publicado: (2016)

‘Failure to fail’: the teacher's dilemma revisited
por: Mak‐van der Vossen, Marianne
Publicado: (2018)

The Economics of Viagra Revisited: The Price Is Right
por: Agochukwu-Mmonu, Nnenaya, et al.
Publicado: (2021)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2023)

Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant
por: Meermeier, Erin W., et al.
Publicado: (2023)

The synergistic effect of sorafenib and TNF-α inhibitor on hepatocellular carcinoma
por: Wang, Mingda, et al.
Publicado: (2019)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Commentary: A technical revisit to the glabellar flap
por: Singh, Manpreet, et al.
Publicado: (2022)

Controlling the obesity pandemic: Geoffrey Rose revisited
por: Frank, John W.
Publicado: (2022)

Revisiting discourse analysis in medical education research
por: Imafuku, Rintaro, et al.
Publicado: (2022)

The not-for-profit form and translational research: Kerr revisited?
por: Joiner, Keith A
Publicado: (2005)

Concurrency revisited: increasing and compelling epidemiological evidence
por: Mah, Timothy L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o5a5lmdlq4r3lpe5a5debpvbnb